Showing results (11-20 of 3,356) with videos related to
Sort By:
Pageof 336
Journal of Internal Medicine|October 15, 2016
Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular linksE M Ribe, S LovestoneJournal of Neurology, Neurosurgery, and Psychiatry|August 20, 2002
Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's diseaseD Liolitsa, J Powell, S LovestoneMolecular Psychiatry|January 23, 2002
Identification of genomic organisation, sequence variants and analysis of the role of the human dishevelled 1 gene in late onset Alzheimer's diseaseC Russ, S Lovestone, J F PowellInternational Journal of Geriatric Psychiatry|April 4, 1998
Clinical predictors of aggressive behaviour in Alzheimer's diseaseN Gormley, M R Rizwan, S LovestoneMolecular Psychiatry|April 28, 2001
Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's diseaseC Russ, S Lovestone, J F PowellMethods in Molecular Medicine|February 15, 2011
Tau phosphorylation both in vitro and in cellsC H Reynolds, G M Gibb, S LovestoneThe British Journal of Psychiatry : the Journal of Mental Science|January 3, 2001
Genetic risk of Alzheimer's disease: advising relativesM B Liddell, S Lovestone, M J OwenJournal of Human Hypertension|May 30, 2001
Association study of the 5-HT(2A) receptor gene polymorphism, T102C and essential hypertensionD Liolitsa, J F Powell, M Prince, et al.Molecular Medicine Today|February 1, 2000
Does dysregulation of the Notch and wingless/Wnt pathways underlie the pathogenesis of Alzheimer's disease?B H Anderton, R Dayanandan, R Killick, et al.Neuroscience|August 1, 1996
Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubulesS Lovestone, C L Hartley, J Pearce, et al.Pageof 336